| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Kymera Therapeutics, Inc. | Chief Business Officer | Common Stock | 50.1K | $104K | $2.08 | Apr 8, 2025 | Direct |
| Kymera Therapeutics, Inc. | Chief Business Officer | Stock Option (Right to Buy) | 100K | Apr 8, 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| KYMR | Kymera Therapeutics, Inc. | Apr 8, 2025 | 2 | $0 | 4 | Apr 9, 2025 | Chief Business Officer |
| KYMR | Kymera Therapeutics, Inc. | Apr 8, 2025 | 0 | $0 | 3 | Apr 9, 2025 | Chief Business Officer |